Correlation Between Mereo BioPharma and Viking Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Viking Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Viking Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Viking Therapeutics, you can compare the effects of market volatilities on Mereo BioPharma and Viking Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Viking Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Viking Therapeutics.
Diversification Opportunities for Mereo BioPharma and Viking Therapeutics
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Mereo and Viking is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Viking Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viking Therapeutics and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Viking Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viking Therapeutics has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Viking Therapeutics go up and down completely randomly.
Pair Corralation between Mereo BioPharma and Viking Therapeutics
Given the investment horizon of 90 days Mereo BioPharma Group is expected to generate 0.76 times more return on investment than Viking Therapeutics. However, Mereo BioPharma Group is 1.32 times less risky than Viking Therapeutics. It trades about -0.15 of its potential returns per unit of risk. Viking Therapeutics is currently generating about -0.34 per unit of risk. If you would invest 420.00 in Mereo BioPharma Group on August 27, 2024 and sell it today you would lose (48.00) from holding Mereo BioPharma Group or give up 11.43% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mereo BioPharma Group vs. Viking Therapeutics
Performance |
| Timeline |
| Mereo BioPharma Group |
| Viking Therapeutics |
Mereo BioPharma and Viking Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mereo BioPharma and Viking Therapeutics
The main advantage of trading using opposite Mereo BioPharma and Viking Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Viking Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viking Therapeutics will offset losses from the drop in Viking Therapeutics' long position.| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
| Viking Therapeutics vs. Terns Pharmaceuticals | Viking Therapeutics vs. Akero Therapeutics | Viking Therapeutics vs. Madrigal Pharmaceuticals | Viking Therapeutics vs. Sarepta Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |